Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New method for preparing 1-(6-methylpyridine-3-yl)-2-[4-(methylsulfanyl)phenyl]acetone

A technology of methylsulfanyl and methylpyridine, which is applied in the field of preparation of intermediates, can solve the problems of falling off, easy explosion of the reaction system, etc., and achieves the effect of reducing the danger of easy explosion and avoiding the easy decomposition of heat to generate gas.

Active Publication Date: 2014-03-26
SHANGHAI JIAO TONG UNIV +1
View PDF10 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The amide reagent contains N, O-dimethylhydroxylamine fragments. During the reaction, this fragment will fall off, and the generated N, O-dimethylhydroxylamine is highly irritating and will cause irritation to the eyes, respiratory tract and skin. Stimulating effect, if heated, it will decompose and generate dangerous gases such as carbon monoxide, carbon dioxide, nitrogen oxides, etc., causing the reaction system to be explosive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New method for preparing 1-(6-methylpyridine-3-yl)-2-[4-(methylsulfanyl)phenyl]acetone
  • New method for preparing 1-(6-methylpyridine-3-yl)-2-[4-(methylsulfanyl)phenyl]acetone
  • New method for preparing 1-(6-methylpyridine-3-yl)-2-[4-(methylsulfanyl)phenyl]acetone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Synthesis of isoxazolidin-2-yl-(6-methylpyridin-3-yl)-methanone of formula (III)

[0052] synthetic route:

[0053]

[0054] Under nitrogen protection, 150 g of 6-methylnicotinic acid methyl ester (V) and 120 g of isoxazole hydrochloride (IV) were added to 500 ml of toluene, and the solution was cooled to -20°C. Slowly add 2.2 mol / L tetrahydrofuran solution of isopropylmagnesium chloride into the cooled solution. Reaction temperature is controlled between-20 ℃ to-10 ℃, after stirring for 0.5 hour, add 500ml20% acetic acid solution, separate and remove water phase, evaporate organic solvent under reduced pressure, obtain the formula (III) compound of yellow liquid (152g , 80%).1 H NMR (300MHz, CDCl 3 )δ2.36(t, 2H, J=7.8Hz), 2.59(s, 3H), 3.94(m, 4H), 7.19(d, 1H, J=8.1Hz), 8.01(dd, 1H, J=7.8 Hz, 1.2Hz), 8.94 (s, 1H).

[0055] Synthesis of 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfanyl)phenyl]ethanone of formula (I)

[0056] synthetic route:

[0057]

[0058] Und...

Embodiment 2

[0060] Synthesis of isoxazolidin-2-yl-(6-methylpyridin-3-yl)-methanone of formula (III)

[0061] synthetic route:

[0062]

[0063] Add 230g of sodium carbonate to 600ml of water and cool to 15°C. 120 g of isoxazole hydrochloride (IV) was added thereto. 155 g of 6-methylnicotinoyl chloride (VI) was evenly suspended and dispersed in dichloromethane, and then added to 1% aqueous sodium carbonate solution at 25°C. The mixed solution was stirred for 0.5 hour, the aqueous phase was separated and removed, and the organic phase was washed with water and dried over anhydrous sodium sulfate. The organic solvent was evaporated under reduced pressure to obtain the compound of formula (III) (123 g, 65%) as a yellow liquid.

[0064] Synthesis of 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfanyl)phenyl]ethanone of formula (I)

[0065] synthetic route:

[0066]

[0067] Under nitrogen protection, 191 g of isoxazolidin-2-yl-(6-methylpyridin-3-yl)-methanone (III) was dissolved in 350 ml...

Embodiment 3

[0069] A kind of new method for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfanyl)phenyl]ethanone, will comprise the Grignard reagent of formula (II) and formula (III) Isoxazolidin-2-yl-(6-methylpyridin-3-yl)-methanone is prepared by reacting in the solvent toluene at a molar ratio of 1:1 between -10°C and 0°C product;

[0070] The structural formula of described Grignard reagent is:

[0071]

[0072] Wherein X is a chlorine atom;

[0073] Described isoxazolidin-2-yl-(6-methylpyridin-3-yl)-methanone: it is to comprise the isoxazole salt of formula (IV) and the 6-methyl smoke of formula (V) Methyl acid is prepared by reacting in the solvent toluene in the presence of sodium hydroxide at a molar ratio of 1.5:1.

[0074] The molecular formula of described isoxazole salt is:

[0075]

[0076] Wherein Y is hydrochloric acid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a new method for preparing 1-(6-methylpyridine-3-yl)-2-[4-(methylsulfanyl)phenyl]acetone. The method comprises the step of reacting Grignard reagent of formula (II) with isoxazole-2-yl-(6-methylpyridine-3-yl)-ketone of formula (III) at minus 20 to 0 DEG C to obtain the 1-(6-methylpyridine-3-yl)-2-[4-(methylsulfanyl)phenyl]acetone of formula (I). Compared with the prior art, the method has the advantage of lowering the explosive risk of the reaction system.

Description

technical field [0001] The present invention relates to the preparation method of the intermediate of etoricoxib, especially relate to a kind of intermediate 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfanyl) for preparing etoricoxib ) new method of phenyl] ethyl ketone. Background technique [0002] 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfanyl)phenyl]ethanone (I) is a highly selective cyclooxygenase-2 (COX-2) Inhibitor - an important intermediate of etoricoxib (Etoricoxib). Its performance has been improved compared with traditional non-steroidal anti-inflammatory drugs (NSA IDs), and it has been approved by the China Food and Drug Administration (sFDA) for the treatment of symptoms and signs of osteoarthritis in the acute and chronic phases, as well as for the treatment of acute gout Arthritis. [0003] [0004] The synthesis method of compound (I) is described in many patents and literatures, among which patents WO01 / 07410A1 and US2003 / 0088107A1 describe the synthesis ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D213/50
CPCC07D213/50
Inventor 毛振民詹晓平刘增路兰天隆艳
Owner SHANGHAI JIAO TONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com